mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |